Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Type 2 Diabetes
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment

Participation Requirements

Age
Between 30 years and 60 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT01580813
Collaborators
  • US Department of Veterans Affairs
  • Pfizer
Investigators
Principal Investigator: Irene Schauer, M.D., Ph.D. University of Colorado, Denver